Advertisement

Topics

Latest "Coalition Cure Prostate Cancer" News Stories

04:47 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Coalition Cure Prostate Cancer" found in our extensive news archives from over 250 global news sources.

More Information about Coalition Cure Prostate Cancer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Coalition Cure Prostate Cancer for you to read. Along with our medical data and news we also list Coalition Cure Prostate Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Coalition Cure Prostate Cancer Companies for you to search.

Showing "Coalition Cure Prostate Cancer" News Articles 1–25 of 17,000+

Extremely Relevant

Could Prostate Cancer Be Treated with Aromatherapy in the Future?

Treating prostate cancer could one day be as noninvasive as inhaling certain scented compounds. The idea may not be as far-fetched as it sounds given that new research from investigators at Duke University School of Medicine shows that an olfactory receptor plays a critical role in the progression of prostate cancer. The researchers found that activating an olfactory receptor called OR51E2 in pros...


His Prostate Cancer Becomes Her Struggle, Too

FRIDAY, March 23, 2018 -- Difficulties tied to prostate cancer may not be limited to men. Many wives of men with advanced prostate cancer say their husband's illness has harmed their own health, a new study finds. "Many prostate cancer patients have...

Relevant

How Do You Spot Prostate Cancer Early On? – Tech Times

BBC SportHow Do You Spot Prostate Cancer Early On?Tech TimesProstate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. The American Cancer Society estimates that one in nine men will be diagnosed with prostate cancer in his lifetime. About one in 41 ...Prostate cancer care for older men estimated to cost Medicare $1.2 billionEurekAlert (p...


Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

What you need to knowPSA testing has increased the number of men diagnosed with and treated for prostate cancer, but many of these men would never have experienced any symptoms or death from prostate...

Cowabunga! Can Cow Therapy Cure Cancer?

A hospital in India offers to cure cancer in 11 days with Ayurveda and cow therapy, giving patients a drink of desi cow milk, yogurt, ghee, urine, and dung. It's very unlikely that cow therapy can cure cancer; but in another sense, the author of the book Holy Cancer says it "healed" him.

Medical News Today: Can women get prostate cancer?

Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.

Liquid biopsy technology to improve prostate cancer treatment

Prostate cancer is the second most common cancer in men and the fifth leading cause of death from cancer in men worldwide, according to 2012 numbers. While several viable treatment options for prostate cancer exist, many men affected with prostate cancer will not respond to first-line treatments. Researchers have now developed a new technology for liquid biopsy to identify which patients may not r...

New genetic marker could help diagnose aggressive prostate cancer

(University of Turku) Scientists have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and poorer survival rates of patients. The gene, called ANO7, could play a vital role in improving diagnosis of prostate cancer patients. There are over 50,000 new cases and 11,000 deaths from prostate cancer each year in the UK.

The Case for Platinum Therapy in Prostate Cancer

The arsenal of therapeutic options for men with castration-resistant prostate cancer has steadily grown as ongoing research uncovers more about prostate cancer biology and resistance mechanisms. 

Prostate Cancer Risk Prediction Improved by DNA Test Sensitive to New Gene Variants

New testing strategies for prostate cancer, including noninvasive saliva tests, may be close to hand, now that an in-depth study of DNA samples from more than 140,000 men has implicated 63 additional genetic variants in prostate cancer risk. By adding the newfound variants to previously known prostate cancer risk variants, scientists based at the Institute of Cancer Research (ICR), London, have de...

Immunotherapy for Prostate Cancer: Where Do We Go From Here?—PART 1: Prostate Cancer Vaccines

The first article in this two-part series will provide an overview of both past and present therapeutic vaccination strategies for the promotion of antitumor immunity against prostate cancer.

Health Tip: Identifying Risk Factors for Prostate Cancer

-- Prostate cancer is rare in men younger than 40, but as a man reaches 50, his chances of getting the disease increase. About 6 in 10 prostate cancers are found in men older than 65, the American Cancer Society says. The ACS mentions these risk...

Immunotherapy could stop prostate cancer spreading, trial shows – The Guardian

The GuardianImmunotherapy could stop prostate cancer spreading, trial showsThe GuardianMen with otherwise untreatable prostate cancer could halt its spread and survive longer by undergoing immunotherapy treatment, a trial has shown. More than a third of men with an advanced form of the cancer were still alive and one-in-10 had not seen ...Prostate cancer breakthrough as new drug keeps men with pre...

Blacks With Prostate Cancer May Fare Better Than Whites

FRIDAY, June 1, 2018 -- Black men with advanced prostate cancer who get chemotherapy may live longer than white men, a new study suggests. Data from nine trials including more than 8,000 men with advanced prostate cancer showed that survival for...

Smell receptor fuels prostate cancer progression

(Duke University) Researchers have found that an olfactory receptor plays a critical role in the progression of prostate cancer. They found that activating the receptor -- called OR51E2 -- in prostate cancer cells caused the cancer to morph into the more aggressive, castration-resistant form of the disease. The finding suggests that taking the opposite approach -- blocking the receptor with specif...

Landmark study links tumour evolution to prostate cancer severity

Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has...

May announces £75m prostate cancer boost

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. In February it was announced that it had overtaken breast cancer as the third biggest killer in cancer and just yesterday it was revealed that 40% of prostate cancers are diagnosed late, at which point treatment becomes increasingly difficult. Image caption:  ...

Could an Early Supper Lower Breast, Prostate Cancer Risk?

WEDNESDAY, July 18, 2018 -- Having a late dinner and heading straight to bed may boost your risk of breast or prostate cancer, a new study suggests. Spanish researchers analyzed data from 621 prostate cancer patients and 1,205 breast cancer...

Despite High PSA Level, Prostate Cancer Subtype May Have a Promising Prognosis

Conventional wisdom suggests that a high level of the protein prostate specific antigen (PSA) in men with prostate cancer means a poor prognosis. However, this may not always be the case in men with a particular subtype of prostate cancer, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers.

Keytruda offers significant hope in subset of prostate cancer

Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at ASCO, a team from The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust were able to use MSD’s Keytruda to good effect in 38% of men. There were 258 men on the study for the treatment of advanced prostate cancer and 38% of those were still al...

Advanced Prostate Cancer Variant More Common Than Thought

WEDNESDAY, July 11, 2018 -- The incidence of treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC) is 17 percent among patients with metastatic castration-resistant prostate cancer (mCRPC), and many t-SCNC biopsy specimens have...

CANCER de la PROSTATE : 150 gènes de susceptibilité pour 30% du risque génétique

À l'heure actuelle, la seule façon de dépister le cancer de la prostate est le test sanguin PSA (Prostate Specific Antigen). Malheureusement, les niveaux de PSA peuvent être augmentés pour d’autres raisons qu’un cancer de la prostate. Le test PSA peut ainsi « laisser passer » certains patients atteints de la maladie, mais peut également conduire à […]

Prostate cancer victims denied ‘game-changing’ drug – Telegraph.co.uk

Telegraph.co.ukProstate cancer victims denied 'game-changing' drugTelegraph.co.ukMen with advanced prostate cancer will be refused a “game-changing” drug on the NHS, after a ruling by rationing watchdogs. Cancer experts said the decision would affect thousands of men who hoped to be able to access the treatment, which has far fewer ...Prostate cancer symptoms: Is the disease terminal? What to ...

Prostate cancer symptoms: Is the disease terminal? – Express.co.uk

Express.co.ukProstate cancer symptoms: Is the disease terminal?Express.co.ukProstate cancer is the most common cancer affecting men, and it kills more than 11,250 men each year. Here are the risk factor you should be aware of. Play slideshow. Prostate cancer - Here are the risk factors you should be aware of. Getty. 1 of 9 ...Thousands of men battling prostate cancer DENIED 'game-changing' drugThe...

Colorectal Cancer Screening Should Begin at Age 45: Coalition

A coalition of healthcare organizations is urging the United States Preventive Services Task Force to update its recommendation on colorectal cancer screening and lower the starting age from 50 to 45 years. Medscape Medical News


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks